| Financial Year |
March 31 2023 |
| Monetary Funds |
63,860,883.57 |
| Held-for-trading Financial Assets |
58,759.44 |
| Notes Receivable |
-- |
| Accounts Receivable |
147,652,315.81 |
| Advances to Suppliers |
62,316,298.14 |
| Other Receivables |
1,076,856,113.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
28,553,293.70 |
| Inventories |
12,100,923.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,097,931.47 |
| Total Current Assets |
1,374,943,225.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
517,665,267.14 |
| Investment Properties |
-- |
| Fixed Assetes |
145,001,980.35 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,724,799.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,644,207.41 |
| Deferred Income Tax Assets |
12,084,195.69 |
| Other Non-Current Assets |
71,112.98 |
| Sub-Total of Non-Current Assets |
1,104,475,648.28 |
| Total Assets |
2,479,418,874.12 |
| Short-Term Loans |
597,783,238.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
625,154,446.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
138,571,941.45 |
| Taxes Payable |
9,889,418.72 |
| Interest Payable |
86,079,064.50 |
| Dividend Payable |
37,212,456.44 |
| Other payables |
607,368,031.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
889,809,337.48 |
| Other Current Liabilities |
14,567,048.37 |
| Sub-Total of Current Liabilities |
3,103,332,610.29 |
| Long-term Loans |
5,030,661.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
52,481,595.75 |
| Deferred Income Tax Liabilities |
194,922.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,738,406.34 |
| Total Liabilities |
3,182,071,016.63 |
| Paid-In Capital(Or Share Stock) |
803,000,258.00 |
| Capital Surplus |
641,038,687.39 |
| Surplus Reserve |
63,942,161.85 |
| LESS:Treasury Stock |
9,207,105.00 |
| Undistributed Profits |
-1,573,635,535.77 |
| Minority Stockholder's Interest |
244,738,826.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-947,390,968.89 |
| Owner's Equity（Stockholder's Equity） |
-702,652,142.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,479,418,874.12 |
